EFFECTIVENESS OF CONSERVATIVE MYOMECTOMY FOR PRESERVATION OF WOMEN'S REPRODUCTIVE CAPACITY

Yaroslav Stepanets

doi:10.31435/ws.1(87).2025.3166

Yaroslav Stepanets Shupyk National University of Healthcare of Ukraine, Kyiv

DOI: https://doi.org/10.31435/ws.1(87).2025.3166

Keywords: Female Reproductive System, Myoma, Hysteroscopy, PTSD, Laparoscopy

Abstract

Over the past few years, the population of Ukraine has faced a number of traumatic events. These events have a negative impact on the life of all Ukrainians and cause an increase in the frequency and severity of stress disorders. However, the biggest shock was the beginning of the active phase of the war in February 2022 in Ukraine. Women develop post-traumatic stress disorder (PTSD) under the influence of super-extreme situations. Amidst stress and PTSD, women experience changes in hormonal levels, immune status, and reproductive health issues.

According to current data, about 30% of people exposed to traumatic events will have PTSD and need help. As for the female population, about 10% of adult women and 7% of girls are diagnosed with PTSD in their lifetime. It is also known that women experience PTSD almost 1.5 times more often than men. The prevalence of mental disorders is particularly high among internally displaced persons. In particular, in this cohort, 22% of men and 36% of women develop and are diagnosed with PTSD.

According to WHO, the problem of uterine tumour processes is one of the most important areas of modern medicine. According to the International Classification of Diseases, 10th Revision (ICD-10: D25.0-D25.9), uterine leiomyoma (UGC), as one of the most common tumours of the female reproductive system, ranks among the top gynaecological diseases (GD) and is combined with extragenital (EGD) and genital (GC) pathologies. Studies conducted in recent years have shown that the incidence of LM has shown an upward trend in recent decades and is 35-45% in women over the age of 30. According to scientists, the true incidence of breast cancer is as high as 77%. The incidence of recurrent LM after reconstructive surgery ranges from 2.6 to 50 % of cases. Studies have shown that in 18.0% of patients of early reproductive age, after myomectomy, newly emerging myomatous nodes were detected. The analysis of the results allowed us to conclude that myoma recurrence is 1.2 times more likely to occur in a subgroup of patients with PTSD. It was also found that myoma recurrence occurs mainly in the first two years after surgery.

References

Boyko V.I. Differentiated approach to the surgical treatment of large uterine fibroids / V.I. Boyko, V.A. Terekhov // Zdorovye zhyttia. - 2016. - No. 7 (113). - P. 57-61.

Vdovychenko Y.P. Uterine leiomyoma: etiopathogenesis, prevention, diagnosis and treatment / Y.P. Vdovychenko, O.V. Golyanovsky, V.I. Lepushin // Zdorovye zhinistyny. - 2012. - No. 3 (69). - P. 52-61.

Zhilka N.Ya. Innovative approaches to the treatment of uterine leiomyoma / N.Ya. Zhilka // Zdorovye zhyttia. - 2016. -No. 7 (113). - P. 104-106.

Zaporozhan V.M. Obstetrics and gynecology: national textbook / V.M. Zaporozhan, T.F. Tatarchuk, I.Z. Gladchuk; edited by V.M. Zaporozhan. - K.: VSV “Medicine”, 2014. - Vol. 4. - P. 290-321.

Panfamirov Y.N. Organ-preserving approach in the treatment of uterine fibroids / Y.N. Panfamirov, V.A. Zabolotnov, O.V. Karapetyan // Zdorovye zhinomy. - 2013. - No. 1 (77). - P. 162-164.

Principles of treatment of uterine leiomyoma / N.V. Kosey, L.A. Vasilchenko, E.I. Sukhorebral, I.I. Shokalo // Reproductive endocrinology. - 2012. - No. 1 (3). - P. 14-20.

Sidorova I.S. Uterine fibroids (modern aspects of etiology, pathogenesis, classification and prevention) / Uterine fibroids; edited by I.S. Sidorova - Moscow: MIA, 2013. - P. 5-66.

Storozhuk MS Clinical characteristics of women of reproductive age with uterine fibroids / MS Storozhuk, Protsenko O.O., Martynyshyn O.B. // Healthy women. - 2012. - No. 7 (73). - P. 16-157.

Modern views on the etiology, pathogenesis and treatment of uterine leiomyoma in women of reproductive age (review of the literature) / A. G. Kornatska, I. I. Raksha, I. S. Kolesnichenko, G. V. Chubey // Zdorovye zhynomy. - 2015. - No. 1 (97). -P. 10-13.

Modern views of a reproductive specialist on the etiopathogenesis and treatment of uterine leiomyoma / N.V. Avramenko, D.E. Barkovsky, O.V. Kabachenko, D.V. Letsyn // Zaporizhzhia Medical Journal. - 2017. - Vol. 19, No. 3 (102). -С. 381-386.

Chaika K.V. Comprehensive endosurgical treatment of women of reproductive age with submucous fibroids / K.V. Chaika, O.L. Pisareva // Medical and social problems of the family. - 2013. - Vol. 18, No. 3. - P. 63-67.

Sharafutdinov B.M. Optimization of X-ray endovascular embolization of uterine arteries in the treatment of patients with uterine fibroids and uterine bleeding / B.M. Sharafutdinov, R.F. Akberov, A.Z. Sharafeev // Practical Medicine. Practical medicine. - 2015. - No. 1 (86). - P. 94-97.

Alterations in uterine hemodynamics caused by uterinebroids and their impact on in vitro fertilization outcomes / Jei-Won Moon, Chung-Hoon Kim, Jun-Bum Kim [et al.] // Clin. Exp. Reprod. Med. – 2015. – Vol. 42 (4). – P. 163–168.

Cell-type specic actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth /S. Yoshida, N. Ohara, Q. Xu [et al.] // Semin. Reprod. Med. – 2010. – Vol. 28. – P. 260–273. 101ISSN 1681-2786.

Clark N. A.Reproductive impact of MRI-guided focused ultrasound surgery for broids: a systematic review of theevidence / N. A. Clark, S. L. Mumford, J. H. Segars // Curr. Opin. Obstet. Gynecol. –2014. – Vol. 26 (3). – P. 151–161.

Deligdish L.Endometrial changes associated with myomata of uterus // L. Deligdish, M.Loewenthal // J. CHn Pathol. –2014. – No. 23. – P. 676–680.

Foissac R.Torsion of a huge pedunculated uterine leiomyoma / R. Foissac, N. Sautot Vial, L. Birtwisle // Am. J. Surg. –2015. – Vol. 201. – P. 43–45.

GSTM1 gene expression correlates to leiomyoma volume regression in response to mifepristone treatment /M. Engman, S. Varghese, Kr. Lagerstedt Robinson [et al.] / PLoS One. – 2013. – Vol. 8 (12).

Hysteroscopy after uterine broid embolization: evaluation of intrauterine еndings in 127 patients / M. Mara,P. Horak, K. Kubinova [et al.] // J. Obstet. Gynaecol. Res. – 2012. – Vol. 38. – P.823–831.

Infertility and uterinebroids / L. I. Zepiridis, G. F. Grimbizis, B. C. Tarlatzis [et al.] // Best Pract. Res. Clin. Obstet Gynaecol. – 2016. – Vol. 34. – P. 66–73.

Intramuralleoimyoma without endometrial cavity distortion may negatively affect the ICSI - ET outcome / S. Guven,C. Kart, M. A. Unsal, E. Odaci // Reprod. Biol. Endocrinol. – 2013. – Vol. 11. – P. 102. doi: 10.1186/1477-7827-11-102

Mauro A. Effect of antiprogesterone RU486 on VEGF expression and blood vessel remodeling on ovarian folliclesbefore ovulation / A. Mauro, A. Martelli, P. Berardinelli // PLoS One. – 2014. – Vol. 9 (4). – P. e95910

Pohl O.The clinical pharmacology and pharmacokinetics of ulipristal acetate for the treatment of uterine¾broids /O. Pohl, R. H. Zobrist, J.-P. Gotteland // Reprod. Sci. – 2015. – Vol. 22 (4). – P. 476–483.

Pohl O.Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day / O. Pohl,I. Osterloh, J. P. Gotteland // J. Clin. Pharm. Ther. – 2013. – Vol. 38 (4). – P. 314–320.

Potentialof minimally invasive procedures in the treatment of uterine¾broids: a focus on magnetic resonance-guidetfocused ultrasound therapy / K. Fischer, N. J. McDannold, C. M. Tempany // Int. J. Womens Health. – 2015. –Vol. 7. – P. 901–912.

Sabry M.Innovative oral treatments of uterine leiomyoma / M. Sabry, A. Al-Hendy // Hindawi Publishing Corporation,Obstetrics and Gynecology International. – P. 1–10. Article ID 943635, doi:10.1155/2012/94363530. Identifying patients who can improve fertility with myomectomy / T. Samejima, K. Koga, H.Naake [et al.] // Eur. J.Obstet. Gynecol. Reprod. Biol. – 2015. – Vol. 185. – P. 28–32.

Shchukina N. A.The clinical and morphological features of uterine myoma in young women / N. A. Shchukina,E. N. Sheina, I. V. Barinova // Rossiysky vestnik akushera ginekologa. – 2014. – No.5. – P. 28–31.

Sunkara S. K.The effects of intramural broids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis / S. K. Sunkara, M. Khairy, T. El-Toukhy [et al.] // Hum. Reprod. – 2010. –Vol. 25 (2). – P. 418–429.

Suzuki K. Recombinant H2 relaxin inhibits apoptosis and induces cell proliferation in ultured leiomyoma cells without affecting those in cultured normal myometrial cells / K. Suzuki, K. Nakabayashi, A. Y. Yamada // Fertil Steril. – 2012. –Vol. 97 (3). – P. 734–741.

Tristan M.Mifepristone for uterine¾broids / M. Tristan, L. J. Orozco, A. Steed // Cochrane Database Syst. Rev. – 2012. –Issue 8. CD007687.

Laganà AS, Alonso Pacheco L, Tinelli A, Haimovich S, Carugno J, Ghezzi F, Mazzon I, Bettocchi SJ. (2019). Management of Asymptomatic Submucous Myomas in Women of Reproductive Age: A Consensus Statement from the Global Congress on Hysteroscopy Scientific Committee. Minim Invasive Gynecol. 26(3):381-3. doi: 10.1016/j.jmig.2018.06.020.